Read more
10:29 PM ยท 9 January 2024

Bitcoin in $47,000 zone ๐Ÿ“Š Top US lawyers cited by Gasparino comment Gensler's statement

Bitcoin entered in strong resistance zone of $47.000 again before tomorrow's final SEC decision about Ark Invest and 21 shares spot Bitcoin ETFs. Valkyrie CIO signalled 95% probability of spot ETF approval and Fox Business reporter, Charles Gasparino cited anonymous sources in top US securities lawyers who deal with the SEC.

  • As we can read in the Gasparino's statement recent crypto warnings by the SEC chair, Gary Gensler may be a prelude to the imminent spot Bitcoin ETF approval and should be taken as a warning to investors because that's what the SEC as the agency usually does. Gensler signalled on X that Bitcoin is a speculative, volatile asset and other digital assets 'are not the same as BTC'. SEC chair signalled also that governments may take regulatory steps that are bad for Bitcoin and crypto ecosystem has been populated 'by lawbreakers'. 

On the other hand, Gensler's comments may also signal that agency is still skeptical about Bitcoin as a both speculative and transaction-used asset. SEC didn't comment any speculation about final Bitcoin ETF decision and theoretically it still could be negative for issuers, but in this case the reason should be another than previously cited by the regulators.

Source: xStation5

8 May 2026, 9:39 PM

Daily Summary: Technology Drives Wall Street to Record Highs Despite Tensions in the Persian Gulf

7 May 2026, 9:52 AM

Morning Wrap: USโ€“Iran Peace Talks in the Shadow of Trumpโ€™s Ultimatum

6 May 2026, 9:38 PM

Technical analysis: Bitcoin gains and approaches important resistance zone

4 May 2026, 1:48 PM

Crypto news ๐Ÿ“ˆ Bitcoin rebounds approaching $80k level

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.